abrdn Healthcare Investors

Veradermics advances oral minoxidil VDPHL01 trials, male phase 3 recruited

JPMorgan lowers Insmed price target to $179, maintains Overweight rating

Amgen Presents New Data on Cardiometabolic Portfolio at ADA Scientific Sessions

Swedish Fourth Pension Fund Reduces Amgen Stake by 3.5% Amid Strong Quarterly Earnings

Insmed Chief Medical Officer Martina Flammer Sells 4,424 Common Shares

Westfield Capital Reduces Insmed Stake as Company Beats Earnings and Bank of America Raises Target Price

argenx CFO Emphasizes 2030 Target to Treat 50,000 Patients and Strong Q1 Performance

Amgen Q1 Revenue Up 6%: Executives Highlight MariTide Potential and AI Strategy to Overcome Challenges

Amgen CFO Peter Griffiths to Speak at Goldman Sachs Global Healthcare Conference on June 9

Amgen CEO Bradway: AI Reshapes Drug Lifecycle, Company Accelerates Transformation

Argenx Announces Phase II Expansion Results for Efgartigimod in Myositis and Sjogren's, Stock Falls 4.06%

Veradermics Gets Buy Rating from Needham, VDPHL01 Hair Loss Drug Peak Revenue Could Reach $2.5 Billion

European Commission Approves Amgen's Imdylltra for Extensive-Stage Small Cell Lung Cancer

BeiGene and Amgen's Bispecific Antibody Aytept Approved by NMPA for SCLC Treatment

Amgen (AMGN) Joins $27 Million Series A Funding Round for Ember LifeSciences

Veradermics to Release Phase II/III Topline Data for VDPHL01 on May 30

ABN Amro and others increase stakes in Insmed, whose revenue beats expectations but stock falls

Insmed General Counsel Michael A. Smith Sells 6,149 Shares for ~$667k

Biogen and Denali Therapeutics Discontinue Development of Parkinson's Drug BIIB122 Due to Failed Trial

Insmed CEO William Lewis Sells $2.72M Stock and Exercises Options

CCSC Tech

Youlife

Core AI

Regentis Biomaterials

Epsium Enterprise

Autozi Internet Tech Global

Leslies

Mega Matrix

eLong Power

Smart Logistics Global

Aberdeen Investments U.S. Closed-End Funds have announced distribution dates and amounts for various funds. Distributions will be paid on May 29, 2026, to shareholders of record as of May 21, 2026. Specific funds, including abrdn Healthcare Investors and abrdn Life Sciences Investors, will pay distributions on June 30, 2026. Shareholders can choose to receive distributions in cash or newly issued shares, with details on the valuation and payment process provided. The distribution policy is subject to change by the Board of Directors/Trustees.

prnewswire

abrdn Life Sciences Investors

abrdn Healthcare Opportunities

abrdn Income Credit Strategies Fund

abrdn Global Income Fund

abrdn Global Dynamic Dividend Fund

abrdn Total Dynamic Dividend Fund

abrdn Global Infrastructure Income Fund

abrdn Global Premier Properties Fund

abrdn Asia-Pacific Income Fund

abrdn Australia Equity Fund

abrdn World Healthcare

India Fd

abrdn National Municipal Income Fund

16:17 ETCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

Shares of abrdn Life Sciences Investors (NYSE:HQL) reached a new 52-week high of $18.10, closing at $18.1250 with a trading volume of 68,327 shares. The stock has seen a 1.7% increase and has a 50-day moving average of $16.88. The company recently raised its quarterly dividend to $0.56 per share, yielding 12.3%. Institutional investors have increased their stakes, with 32.21% of the stock owned by such entities. The company focuses on investments in the life sciences sector, including biotechnology and pharmaceuticals.

Market Beat

abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week High  - Time to Buy?

Wolverine Asset Management LLC has made a new investment of approximately $2.78 million in abrdn Healthcare Investors (NYSE:HQH), acquiring 146,779 shares during the fourth quarter. This investment represents 0.27% ownership in the company. Other hedge funds, including Raymond James Financial and Penserra Capital Management, have also increased their stakes in abrdn Healthcare Investors. The company recently declared a quarterly dividend of $0.63, up from $0.57, reflecting a 12.7% yield. abrdn Healthcare Investors focuses on long-term capital appreciation in the healthcare sector.

Raymond James Financial

ROYAL BANK OF CANADA

Ameriprise Financial

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

Wolverine Asset Management LLC Makes New $2.78 Million Investment in abrdn Healthcare Investors $HQH

abrdn Healthcare Investors (NYSE:HQH) stock price has crossed above its 50-day moving average of $18.79, reaching a high of $19.64 during trading. The stock last traded at $19.4890, down 0.6%. The company recently increased its quarterly dividend to $0.63, yielding 12.9%. Institutional investors have been active, with several increasing their stakes in the stock. Currently, 32.60% of the stock is owned by institutional investors and hedge funds. Analysts maintain a Hold rating on the stock, suggesting it may not be the best buy at this time.

abrdn Healthcare Investors (NYSE:HQH) Stock Price Crosses Above 50 Day Moving Average   - Should You Sell?

abrdn Life Sciences Investors (NYSE:HQL) reached a new 52-week high of $18.10, closing at $18.00 with a trading volume of 134,715 shares. The company recently increased its quarterly dividend from $0.50 to $0.56, yielding 12.5%. Institutional investors have significantly increased their stakes, with Shaker Financial Services growing its position by 536.8%. abrdn Life Sciences Investors focuses on capital appreciation in the life sciences sector, investing in biotechnology, pharmaceuticals, and healthcare technology.

LPL Financial

abrdn Life Sciences Investors (NYSE:HQL) Sets New 1-Year High  - Here's Why

abrdn Healthcare Investors (NYSE:HQH) experienced a significant decline in short interest, dropping 20% in March to 61,693 shares. This represents 0.1% of the company's shares. The short-interest ratio is 0.4 days based on an average daily trading volume of 146,576 shares. Institutional investors have increased their stakes, with Morgan Stanley growing its position by 11.5%. The stock rose 1.0% to $19.95, with a dividend increase to $0.63 per share, yielding 12.6%.

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

abrdn Healthcare Investors (NYSE:HQH) Short Interest Update

NDIA

ASGI

Aberdeen Investments U.S. Closed-End Funds announced distribution payments on March 31, 2026, for shareholders of record as of March 24, 2026. The funds include ASGI, HQH, HQL, IAF, IFN, and THQ, with varying distribution amounts per share. Certain funds automatically paid distributions in newly issued shares unless cash was requested. The estimated sources of distributions include net investment income, realized gains, and return of capital, with specific percentages outlined for each fund. Shareholders had to notify their brokers by March 17, 2026, to receive cash instead of shares.

MorningStar

Global X India Active ETF

Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

Shares of Abrdn Healthcare Investors (HQH) fell below their 200-day moving average of $17.86, trading as low as $17.75, down about 2% on the day. The 52-week range for HQH is between $13.77 and $20.46, with the last trade at $17.50. This movement indicates a significant shift in trading performance for the stock.

nasdaq

HQH Crosses Below Key Moving Average Level

abrdn Healthcare Opportunities Fund declares $0.18 dividend

businessinsider

abrdn Healthcare Opportunities Fund declares $0.18 dividend

abrdn Healthcare Investors(HQH.US)

16:17 ETCertain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week High - Time to Buy?

Wolverine Asset Management LLC Makes New $2.78 Million Investment in abrdn Healthcare Investors $HQH

abrdn Healthcare Investors (NYSE:HQH) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?

abrdn Life Sciences Investors (NYSE:HQL) Sets New 1-Year High - Here's Why